GLP-1 drugs may reduce the risk of cancer progressing, study suggests

A new study suggests that GLP-1 drugs, commonly used for diabetes and weight loss, may help reduce the risk of cancer progression. The research indicates potential benefits of these medications beyond their primary therapeutic uses. Further investigation is needed to understand the mechanisms behind this protective effect.